Carboxyl-Terminal Src Kinase Binds CD28 upon Activation and Mutes Downstream Signaling

  • Skånland S
  • Taskén K
7Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Full T cell activation depends on stimulation of the TCR in conjunction with a costimulatory receptor. The involvement of costimulatory molecules is potent, and a mechanistic understanding of how downstream signaling is regulated is required to fully understand T cell responsiveness. In this study, a proteomic approach was taken to identify the interactomes of the coreceptors CD2 and CD28. These coreceptors are both positive regulators of T cell activation, but CD28 less potently induces TCR-proximal signaling. C-terminal Src kinase (CSK), a negative regulator of TCR signaling, was identified as a specific and direct interactor only of activated CD28. CSK is recruited to CD28 upon T cell activation, and the in vitro kinase activity of CSK is enhanced in the presence of phosphorylated CD28. Interruption of the CSK/CD28 interaction prior to TCR/CD28 costimulation induces a signaling response which mimics the more potent CD2-induced TCR-proximal pathway activation. Thus, CD28 functions as a novel adaptor protein for CSK, and CSK regulates signaling downstream of CD28.

Cite

CITATION STYLE

APA

Skånland, S. S., & Taskén, K. (2019). Carboxyl-Terminal Src Kinase Binds CD28 upon Activation and Mutes Downstream Signaling. The Journal of Immunology, 203(4), 1055–1063. https://doi.org/10.4049/jimmunol.1801660

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free